Arecor Therapeutics PLC
F:6UI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Arecor Therapeutics PLC
F:6UI
|
UK |
|
T
|
Tong Hua Holding PCL
SET:TH
|
TH |
Intrinsic Value
The intrinsic value of Arecor Therapeutics PLC (6UI) under the Base Case is 0.69 EUR per share. Compared with the current market price of 0.8 EUR, the stock appears Overvalued by 14% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Arecor Therapeutics Does
Arecor Therapeutics is a drug formulation company. It does not make and sell a broad range of medicines itself; instead, it develops ways to improve how existing drugs are formulated, stored, and delivered, especially injectable medicines such as insulin and other biologics. Its work focuses on making treatments more stable, easier to use, and better suited to real-world patient care.
- Headquarters
- United Kingdom UK
- Employees
- 33
- IPO date
- Jun 3, 2021
Earnings Waterfall
Arecor Therapeutics PLC
The intrinsic value for Arecor Therapeutics PLC (6UI) under the Base Case is 0.69 EUR.
Compared with the current market price of 0.8 EUR, the stock appears Overvalued by 14% .